174 related articles for article (PubMed ID: 30111351)
1. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases.
Ding Y; Wang C; Li X; Jiang Y; Mei P; Huang W; Song G; Wang J; Ping G; Hu R; Miao C; He X; Chen G; Li H; Zhu Y; Zhang Z
Diagn Pathol; 2018 Aug; 13(1):54. PubMed ID: 30111351
[TBL] [Abstract][Full Text] [Related]
2. BRAF mutations in metanephric adenoma of the kidney.
Choueiri TK; Cheville J; Palescandolo E; Fay AP; Kantoff PW; Atkins MB; McKenney JK; Brown V; Lampron ME; Zhou M; Hirsch MS; Signoretti S
Eur Urol; 2012 Nov; 62(5):917-22. PubMed ID: 22727996
[TBL] [Abstract][Full Text] [Related]
3. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma.
Udager AM; Pan J; Magers MJ; Palapattu GS; Morgan TM; Montgomery JS; Weizer AZ; Hafez KS; Miller DC; Wolf JS; McHugh JB; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Am J Surg Pathol; 2015 Apr; 39(4):549-57. PubMed ID: 25602792
[TBL] [Abstract][Full Text] [Related]
4. [Molecular features of metanephric adenoma and their values in differential diagnosis].
Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975
[No Abstract] [Full Text] [Related]
5. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
[TBL] [Abstract][Full Text] [Related]
6. BRAF mutations in pediatric metanephric tumors.
Chami R; Yin M; Marrano P; Teerapakpinyo C; Shuangshoti S; Thorner PS
Hum Pathol; 2015 Aug; 46(8):1153-61. PubMed ID: 26014474
[TBL] [Abstract][Full Text] [Related]
7. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.
Catic A; Kurtovic-Kozaric A; Sophian A; Mazur L; Skenderi F; Hes O; Rohan S; Rakheja D; Kogan J; Pins MR
BMC Med Genet; 2020 Oct; 21(1):202. PubMed ID: 33046021
[TBL] [Abstract][Full Text] [Related]
8. BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors.
Marsden L; Jennings LJ; Gadd S; Yu M; Perlman EJ; Cajaiba MM
Hum Pathol; 2017 Feb; 60():32-36. PubMed ID: 27769870
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical phenotype and molecular pathological characteristics of metanephric adenoma.
Sun Z; Kan S; Zhang L; Zhang Y; Jing H; Huang G; Yu Q; Wu J
Int J Clin Exp Pathol; 2015; 8(6):6031-6. PubMed ID: 26261480
[TBL] [Abstract][Full Text] [Related]
10. Paediatric metanephric tumours: a clinicopathological and molecular characterisation.
de Jel DVC; Hol JA; Ooms AHAG; de Krijger RR; Jongmans MCJ; Littooij AS; Drost J; van Grotel M; van den Heuvel-Eibrink MM
Crit Rev Oncol Hematol; 2020 Jun; 150():102970. PubMed ID: 32371339
[TBL] [Abstract][Full Text] [Related]
11. A novel cytogenetic and molecular characterization of renal metanephric adenoma: Identification of partner genes involved in translocation t(9;15)(p24;q24).
Catic A; Kurtovic-Kozaric A; Johnson SH; Vasmatzis G; Pins MR; Kogan J
Cancer Genet; 2017 Aug; 214-215():9-15. PubMed ID: 28595733
[TBL] [Abstract][Full Text] [Related]
12. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis.
Pan CC; Tseng CE; Kuroda N; Yano M; Yasuda M; Nagashima Y; Yeh YC; Wang YC; Chang YH; Epstein JI
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):257-263. PubMed ID: 35384875
[TBL] [Abstract][Full Text] [Related]
14. Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.
Caliò A; Eble JN; Hes O; Martignoni G; Harari SE; Williamson SR; Brunelli M; Osunkoya AO; Wang L; Comperat E; Lopez-Beltran A; Wang M; Zhang S; Curless KL; Post KM; Chang HY; Luchini C; Baldrige LA; MacLennan GT; Montironi R; Grignon DJ; Cheng L
Oncotarget; 2017 Aug; 8(33):54096-54105. PubMed ID: 28903326
[No Abstract] [Full Text] [Related]
15. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?
Dadone B; Ambrosetti D; Carpentier X; Duranton-Tanneur V; Burel-Vandenbos F; Amiel J; Pedeutour F
Cancer Genet; 2013; 206(9-10):347-52. PubMed ID: 24432405
[TBL] [Abstract][Full Text] [Related]
16. Metanephric adenoma of the kidney: histologic, immunohistochemical and DNA content analysis study. A case report.
Fraggetta F; Galia A; Lopes M; Cosentino A; Vasquez E
Gen Diagn Pathol; 1997 Jul; 143(1):59-62. PubMed ID: 9269909
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation].
Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
[No Abstract] [Full Text] [Related]
18. Metanephric adenoma: molecular study and review of the literature.
Rodríguez-Zarco E; Machuca-Aguado J; Macías-García L; Vallejo-Benítez A; Ríos-Martín JJ
Oncotarget; 2022; 13():387-392. PubMed ID: 35198098
[TBL] [Abstract][Full Text] [Related]
19. Whole-exome sequencing identified mutational profiles of high-grade colon adenomas.
Lee SH; Jung SH; Kim TM; Rhee JK; Park HC; Kim MS; Kim SS; An CH; Lee SH; Chung YJ
Oncotarget; 2017 Jan; 8(4):6579-6588. PubMed ID: 28179590
[TBL] [Abstract][Full Text] [Related]
20. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms.
Azabdaftari G; Alroy J; Banner BF; Ucci A; Bhan I; Cheville JC
Pathol Res Pract; 2008; 204(10):719-23. PubMed ID: 18621486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
